NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Acurx Pharmaceuticals Inc. Common Stock (NASDAQ: ACXP)

 
ACXP Technical Analysis
5
As on 9th Jun 2023 ACXP STOCK Price closed @ 2.81 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.62 & Strong Sell for SHORT-TERM with Stoploss of 4.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACXPSTOCK Price

Open 2.83 Change Price %
High 3.01 1 Day -0.01 -0.35
Low 2.78 1 Week -0.09 -3.10
Close 2.81 1 Month -0.25 -8.17
Volume 39977 1 Year -1.62 -36.57
52 Week High 4.78 | 52 Week Low 2.42
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ACXP
Daily Charts
ACXP
Intraday Charts
Whats New @
Bazaartrend
ACXP
Free Analysis
 
ACXP Important Levels Intraday
RESISTANCE3.25
RESISTANCE3.11
RESISTANCE3.02
RESISTANCE2.94
SUPPORT2.68
SUPPORT2.60
SUPPORT2.51
SUPPORT2.37
 
ACXP Forecast April 2024
4th UP Forecast6.16
3rd UP Forecast5.09
2nd UP Forecast4.42
1st UP Forecast3.76
1st DOWN Forecast1.86
2nd DOWN Forecast1.2
3rd DOWN Forecast0.53
4th DOWN Forecast-0.54
 
ACXP Weekly Forecast
4th UP Forecast3.85
3rd UP Forecast3.52
2nd UP Forecast3.31
1st UP Forecast3.10
1st DOWN Forecast2.52
2nd DOWN Forecast2.31
3rd DOWN Forecast2.10
4th DOWN Forecast1.77
 
ACXP Forecast2024
4th UP Forecast7.74
3rd UP Forecast6.16
2nd UP Forecast5.18
1st UP Forecast4.21
1st DOWN Forecast1.41
2nd DOWN Forecast0.44
3rd DOWN Forecast-0.54
4th DOWN Forecast-2.12
 
 
ACXP Other Details
Segment EQ
Market Capital 50899580.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACXP Address
ACXP
 
ACXP Latest News
 
Your Comments and Response on Acurx Pharmaceuticals Inc. Common Stock
 
ACXP Business Profile
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York. Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service